Home / Clinical trials / Liraglutide
Are there clinical trials for Liraglutide?
Liraglutide has 520 registered clinical trials, including 317 completed interventional studies and trials reaching Phase 4. Its use in humans is supported by established registered clinical evidence.
Trial breakdown
By phase
| Phase 4 | 133 |
| Phase 3 | 113 |
| Phase 2 | 79 |
| Phase 1 | 72 |
| Not applicable | 53 |
| Early Phase 1 | 5 |
By status
| Completed | 368 |
| Unknown status | 67 |
| Recruiting | 26 |
| Terminated | 20 |
| Withdrawn | 17 |
| Active, not recruiting | 11 |
| Not yet recruiting | 5 |
| Enrolling by invitation | 5 |
| Suspended | 1 |
Active trials
- GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF RegistryNot yet recruiting · 150 participants · Miedziowe Centrum Zdrowia SA · started 2027-01-01NCT07787936
- Metabolic Surgery for Atrial Fibrillation EliminationPhase 4 · Not yet recruiting · 100 participants · Ali Aminian · started 2026-11-01NCT07027969
- A Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapyNot yet recruiting · 3718 participants · Novartis Pharmaceuticals · started 2026-10-30NCT07881783
- Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With ObesityRecruiting · 200 participants · Yuzuncu Yil University · started 2026-09-15NCT07901777
- Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor AgonistsRecruiting · 300 participants · Ohio State University · started 2026-06-12NCT07702461
- TP04HN106 in the Treatment of Patients With Amyotrophic Lateral SclerosisPhase 1 / Phase 2 · Recruiting · 60 participants · Talengen Institute of Life Sciences, Shenzhen, P.R. China. · started 2026-06-04NCT06726577
- RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.Phase 4 · Not yet recruiting · 120 participants · The Fourth Affiliated Hospital of Zhejiang University School of Medicine · started 2026-05-01NCT07301437
- A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial NeoplasiaPhase 2 · Recruiting · 20 participants · University of Florida · started 2026-04-07NCT07107334
Most recent registered trials
- GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF RegistryNot yet recruiting · 150 participants · Miedziowe Centrum Zdrowia SA · started 2027-01-01NCT07787936
- Metabolic Surgery for Atrial Fibrillation EliminationPhase 4 · Not yet recruiting · 100 participants · Ali Aminian · started 2026-11-01NCT07027969
- A Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapyNot yet recruiting · 3718 participants · Novartis Pharmaceuticals · started 2026-10-30NCT07881783
- Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With ObesityRecruiting · 200 participants · Yuzuncu Yil University · started 2026-09-15NCT07901777
- Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor AgonistsRecruiting · 300 participants · Ohio State University · started 2026-06-12NCT07702461
- TP04HN106 in the Treatment of Patients With Amyotrophic Lateral SclerosisPhase 1 / Phase 2 · Recruiting · 60 participants · Talengen Institute of Life Sciences, Shenzhen, P.R. China. · started 2026-06-04NCT06726577
- RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.Phase 4 · Not yet recruiting · 120 participants · The Fourth Affiliated Hospital of Zhejiang University School of Medicine · started 2026-05-01NCT07301437
- A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial NeoplasiaPhase 2 · Recruiting · 20 participants · University of Florida · started 2026-04-07NCT07107334
- The Evira Study: Additional Support During Obesity TreatmentNot applicable · Recruiting · 40 participants · Karolinska Institutet · started 2026-02-13NCT06836284
- Estimating the Impact of Obesity Medications on Clinical and Economic OutcomesEnrolling by invitation · 125000 participants · Indiana University · started 2026-01-01NCT07640139
- Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)Phase 1 · Recruiting · 71 participants · Novo Nordisk A/S · started 2025-11-07NCT07225816
- A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidney DiseasePhase 2 · Active, not recruiting · 15 participants · Beijing University of Chinese Medicine · started 2025-10-20NCT07907965
What Liraglutide is being studied for
Most studied conditions
Who is running the studies
Counted from ClinicalTrials.gov registrations, checked 2026-11-09.
Peptides with a similar weight of evidence
Ordered by how far the registered research has progressed.
- Exenatide380 registered studies
- Octreotide328 registered studies
- Tirzepatide312 registered studies
- Teriparatide182 registered studies
- Dulaglutide143 registered studies
Frequently asked questions
Are there clinical trials for Liraglutide?
Liraglutide has 520 registered clinical trials, including 317 completed interventional studies and trials reaching Phase 4. Its use in humans is supported by established registered clinical evidence.
Does a registered trial mean the peptide works?
No. Registration means a study was formally listed before or during the research. It says nothing about the result. A completed trial can find no benefit, and many registered studies are never published.
What is the difference between a registered trial and published evidence?
Registration records that a study exists. Publication reports what it found. This page counts registrations, which is the more complete picture of research activity, but it is not a measure of proven effectiveness.
Why do phases matter?
Phase 1 tests safety in a small group. Phase 2 looks for early signs of effect. Phase 3 tests effectiveness against a comparator in a large group, and is what regulators normally require. Phase 4 studies happen after approval. A compound with only Phase 1 trials has not been shown to work.
Source: ClinicalTrials.gov API v2, U.S. National Library of Medicine. Studies where Liraglutide is registered as an intervention. Last updated 2026-11-09.
Related data
- When generic liraglutide arrives →FDA patent and exclusivity expiry dates
- Which peptides are FDA-approved →Approval status for every peptide, from Drugs@FDA
- Which peptides have clinical evidence →Registered clinical trial counts from ClinicalTrials.gov
- Peptide legality by US state →A sourced verdict for all 50 states
